Table 3.
Patient Characteristics of Nonmetastatic GBM Cases at MSKCC
Median age at diagnosis (y) | 61 (21–90) |
Gender | |
Male | 59% |
Female | 41% |
Site of glioblastoma | |
Temporal | 35.7% |
Frontal | 33.9% |
Parietal | 25.4% |
Occipital | 4.7% |
Corpus callosum | 1.5% |
Thalamus | 2.3% |
Brainstem | 0.9% |
Multifocal | 0.9% |
Basal ganglia | 0.6% |
Cerebellum | 0.3% |
Insula | 0.6% |
Optic nerve | 0.3% |
Number of surgeries | |
1 | 69.3% |
2 | 26.6% |
3 | 3.8% |
4 | 0.3% |
Radiation | |
Yes | 99.1% |
No | 0.9% |
Chemotherapy | |
Yes | 98.8% |
No | 1.2% |
CSF shunt | |
Yes | 6.1% |
No | 93.9% |
MGMT-methylated | |
Yes | 20.5% |
No | 64.3% |
Unknown | 15.2% |
IDH-mutated | |
Yes | 4.1% |
No | 95.9% |
Median OS | 16.9 (2.5-68) |